FDA Approves First in New Class of Antibiotics
George Mason University Scientists Suggest Link Between Smallpox Vaccination and HIV Infection
Key Symptoms Differentiating Inhaled Anthrax From Influenza Identified by NewYork Weill Cornell Study
B. Braun Ultrasite Needle-Free IV System Designed to Help Prevent Exposure to Bloodborne Pathogens in the Radiology Suite
eMerge Begins Development of Human Hand Infection Control Scanning Device
Another Airport Travel Hazard -- Dirty Hands
NIAID Launches Malaria Vaccine Trial in Africa
Maxxim Medical Signs Agreement to be Acquired by Lightyear Capital
Joint Commission Resources Announces Availability of Staff Education Posters
Updated AIDS Treatment Guidelines Recognize Growing Value and Importance of HIV Drug Resistance Testing
NIAID Opens Innovative Treatment Study for West Nile Virus
Clinical Trial Shows Probactrix Effective for Treating Diarrhea Caused by Antibiotics
Chimerix Awarded $36 Million NIH Grant to Develop Oral Drug for Treatment of Smallpox Infection
Air Quality Sciences' Experts to Present at Ground-Breaking Conference
Adults With Asthma Fail to Follow Flu Vaccine Guidelines
Nabi Biopharmaceuticals Successfully Completes StaphVAX Immunogenicity Study
Intradigm Corporation Announces Development of siRNA Inhibitors of SARS coronavirus
Health Action Council Initiative Achieves Significant Antibiotic Prescription Cost Savings
HHS Announces New Regional Centers for Biodefense Research
Non-Toxic Disinfectant Reported to Kill Bubonic Plague Bacteria
National Study Reveals Drop in Unnecessary Use of Antibiotics for Children; Michigan Sees Similar Reduction
PATI Announces Ability to Improve Sick Building Syndrome Safety by Testing for and Measuring Active Mold Growth Without Destruction of Property
ViroLogic Awarded NIH Grant to Develop Hepatitis C Virus Drug Resistance Test
Acambis to Collaborate With Cangene to Develop West Nile Hyperimmune Globulins
Mouse Study Gives New View of Anthrax Toxin
TSO3 Obtains FDA Authorization to Commercialize its Ozone Sterilizer and Chemical Indicator
Par Pharmaceutical Begins Shipment of Ofloxacin Tablets for Bacterial Infections
Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection
Subversive Strep Bug Strategy Revealed
North American Ambulance Alliance Selects Sempermed as Exclusive Glove Supplier
